US Acne & Rosacea Market Research Report forecast 2018-2022
Summary - A new market study, titled “US Acne & Rosacea
Market: Industry Analysis & Outlook (2018-2022)” has been featured on Wise
Guy Reports.
Acne and Rosacea are the
most common dermatological disorders affecting people in the United States.
Acne is a chronic skin disorder in which the hair follicles become blocked
and/or inflamed, which is most prevalent among teenagers. However, some people
may suffer from acne well into their 30s and 40s even. Acne can occur in forms
ranging from comedones to cystic lesions, depending upon severity.
Rosacea is a common skin condition that causes redness and
visible blood vessels on the nose, cheeks, and forehead. Rosacea can occur to
anyone. But it is most commonly affects adults over age 30, particularly women
with fair skin. The condition of rosacea is increasingly widespread in the U.S.
and affecting approximately 16 million population in the country.
Topical drugs currently dominate both markets in the U.S.
Systemic medications such as oral antibiotics, hormonal agents or other drugs
are also used for the treatment of acne and rosacea. The ongoing development of
new drugs is expected to witness an extraordinary growth rate due to higher
efficacy, convenient dosing and fewer side effects.
The increase in emotional burden due to these skin
conditions is a key factor driving the growth of the market. Growing awareness
regarding rosacea and acne treatment options has significantly driven the
market in the U.S. Rising purchasing power and mounting healthcare expenditure
has also fuelled the growth of the market in the region. Despite being common
skin disorders, advancement in treatment has been limited over the past years
exhibiting a great opportunity of growth in the future. The companies are
developing new treatment options, in which, most products are in late-stage
indicating an optimistic future for the market.
The report “U.S. Acne & Rosacea Market: Industry
Analysis & Outlook (2018-2022)” by Koncept Analytics provides an extensive
research and detailed analysis of the present market along with future outlook.
The report discusses the major growth drivers and challenges of the market,
covering the U.S. market. The report profiles the key players of the market
including Bausch Health Companies, Allergan, Foamix Pharmaceuticals and Sol-Gel
Technologies.
FOR MORE DETAILS: https://www.wiseguyreports.com/reports/3652649-us-acne-rosacea-market-industry-analysis-outlook-2018-2022
About
Us :
Wise Guy Reports is part of the Wise Guy Research
Consultants Pvt. Ltd. and offers premium progressive statistical surveying,
market research reports, analysis & forecast data for industries and
governments around the globe.
Contact
Us:
NORAH
TRENT
Ph: +162-825-80070
(US)
Ph: +44 203
500 2763 (UK)
Comments
Post a Comment